Numax(R) Achieves Primary Endpoint In Preliminary Analysis Of Data…
Published by FDA - Topix.net November 7th, 2006 in UncategorizedMedImmune, Inc. today announced preliminary results from a Phase 3 pivotal study showing that Numax met its primary endpoint of non-inferiority by reducing the incidence of hospitalizations caused by …
Comment